Session
Lecturer
Signaling Molecules in Periodontal Regeneration: Revisiting Their Potential
- Significance of Signaling Molecules in Periodontal Regenerative Therapy
- Potential and Challenges of Signaling Molecules
- Synergistic Effects of Signaling Molecules in Combination with Scaffolds and Stem Cells
Among the three pillars of the tissue engineering triad, signaling molecules play a pivotal role in orchestrating tissue regeneration and are indispensable for achieving predictable regenerative outcomes. In Japan, recombinant human basic fibroblast growth factor (FGF-2) has been approved as a therapeutic agent for periodontal regeneration. A decade has passed since its clinical introduction, providing substantial experience regarding its therapeutic efficacy and clinical utility. This presentation aims to consolidate current evidence on the clinical significance of FGF-2 in periodontal regenerative therapy, discuss its future prospects and remaining challenges, and explore its synergistic application with bone graft substitutes and other biomaterials that are expected to further enhance regenerative outcomes.
Lecturer
Biology-driven Selection Criteria for Bone Graft Substitutes
— From Evidence to Clinical Decision-Making —
- Characteristics of bone graft substitutes used in periodontal regenerative therapy
- Biological behavior of bone graft substitutes interpreted from preclinical studies
- Case-based decision-making for material selection in clinical practice
In periodontal regenerative therapy, the selection of bone graft substitutes should not be based solely on product names, handling properties, or familiarity. Rather, it should be guided by an understanding of how each material behaves biologically in vivo, including its space-maintaining capacity, osteoconductive potential, degradation or substitution pattern, and influence on wound healing. In this lecture, I will discuss practical criteria for selecting commercially available bone graft substitutes based on histological insights obtained from our large-animal preclinical studies. By linking biological evidence with clinical cases, I will highlight how differences among materials may influence regenerative outcomes in various defect morphologies and clinical situations. Particular attention will be given to how clinicians can interpret preclinical findings and translate them into daily decision-making. The goal of this presentation is to move beyond a material-centered approach and to propose a biology-guided framework for selecting bone graft substitutes in periodontal regenerative therapy.
Lecturer
歯周組織再生療法におけるバイオマテリアル使用の臨床判断
歯周組織再生療法におけるバイオマテリアル使用の臨床判断
- シグナル分子の重要性
- 骨補填材使用の臨床的有用性
- バリアメンブレンが必要となる条件
- シグナル分子の重要性
- 骨補填材使用の臨床的有用性
- バリアメンブレンが必要となる条件
Periodontal regeneration has advanced toward minimally invasive procedures through the clinical application of signaling molecules, which has in turn led to the development of various surgical techniques. Bone graft materials serve as scaffolds for maintaining the blood clot, and the use of barrier membranes, when necessary, can further enhance treatment outcomes. The development of such biomaterials has significantly expanded the indications for periodontal regeneration. In this lecture, I will discuss clinical decision-making regarding the use of these biomaterials, based on my own clinical experience.







